TABLE A3.
Geometric Mean (Geometric CV%) Plasma PK Parameter of Ripretinib After a Single Oral Dose in Patients With Advanced Malignancies in the Dose-Escalation Phase on Cycle 1 Day 1
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.